已收录 268920 条政策
 政策提纲
  • 暂无提纲
Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine
[摘要] ESCs �? embryonic stem cells; iPSCs �? inducedpluripotent stem cells; Chd1 �? chromodomain helicase DNA-binding protein; BAF �?rg/Brahma-associated factors; miRNA, miR �? microRNA; TERRA �?telomeric-repeat-containing RNA; Cdkn �? cyclin-dependent kinase inhibitor; VPA�? valproic acid; siRNA �? small interfering RNA; KMOS �? Klf4, c-Myc, Oct4, Sox2;KOS �? Klf4, Oct4, Sox2; LNOS �? Lin28, Nanog, Oct4, Sox2; GSK-3 �? glycogensynthase kinase 3; ROS �? reactive oxygen species; HIF1 �? hypoxia-induciblefactor 1; VEGF �? vascular endothelial growth factor.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生物技术
[关键词] cell reprogramming;induced pluripotent stem cells;directed stem cell differentiation;cell replacement therapy [时效性] 
   浏览次数:17      统一登录查看全文      激活码登录查看全文